MARKET STRUCTURE · USA A New Startup Wants to Edit Human Embryos Change Manhattan Genomics has emerged, aiming to edit human embryos to eliminate genetic diseases, reigniting ethical concerns over gene editing. This matters as it raises questions about the implications of heritable genetic modifications. Why it matters Manhattan Genomics, a New York-based startup, is reviving the controversial topic of gene-edited babies by focusing on eliminating genetic diseases at the embryo stage. Founded by Cathy Tie and Eriona Hysolli, the company aims to use advanced gene-editing techniques while navigating ethical concerns and regulatory challenges surrounding human embryo editing. Wired · 6:26 AM More actions Like (sign in) Save (sign in) Share Facebook LinkedIn X / Twitter Copy link
